| Dotan, Iris |
AZITRATIM, NCT05599347: Pre-treatment With Azithromycin to Reduce Immunogenicity to to Anti-TNF Agents in Patients With Crohn's Disease |
|
|
| Recruiting | 2 | 180 | RoW | Azithromycin Pill, Placebo | Rambam Health Care Campus | Crohn's Disease Relapse, Biological Substance; Adverse Effect | 12/25 | 12/26 | | |
Bio-MDT, NCT04082559: Biomarker-based Multidisciplinary Team () Approach to Personalized Microbial-targeted Treatment of Pouchitis and Crohn's Disease |
|
|
| Recruiting | N/A | 170 | RoW | Arm 1- Antibiotics treatment, Ciprofloxacin 500 mg 2/d + metronidazole 500 mg 2/d for two weeks, Arm 2- Antibiotics treatment, Doxycycline 100 mg 2/d + metronidazole 500 mg 2/d for two weeks, Arm 1- Combination therapy (Antibiotics + diet), Favorable antibiotics (according to aim 1) for two weeks + Mediterranean diet (MED) for 8 weeks., Arm 2- Combination therapy (Antibiotics + diet), Favorable antibiotics (according to aim 1) for two weeks + specific carbohydrate diet (SCD) for 8 weeks., Arm 1- Nutritional prevention, Mediterranean diet, Arm 2- Nutritional prevention, Control- based on the American Dietetic Association recommendations for patients with IBD, Arm 3- Nutritional prevention, Personalized nutrition group- based on prior results from study- NCT02858557 | Rabin Medical Center, The Leona M. and Harry B. Helmsley Charitable Trust, Tel Aviv University | Inflammatory Bowel Diseases | 06/21 | 06/23 | | |
IBDMED, NCT05536544: The Inflammatory Bowel Disease Mediterranean Diet () Microbiome-targeting Nutritional Education Program |
|
|
| Recruiting | N/A | 120 | RoW | IBDMED, Control | Rabin Medical Center, Asian Institute of Gastroenterology | Inflammatory Bowel Diseases | 05/23 | 12/24 | | |
| Not yet recruiting | N/A | 2500 | RoW | | Tel-Aviv Sourasky Medical Center | Inflammatory Bowel Disease | 12/26 | 12/26 | | |
| Elinav, Eran |
| Not yet recruiting | N/A | 300 | NA | Fecal microbiome transplant, placebo | Eran Elinav, Assaf-Harofeh Medical Center | Obesity, Weight Loss, FMT | 09/22 | 09/25 | | |
NCT04618705: Gut Microbiome and Weight Gain After Smoking Cessation |
|
|
| Withdrawn | N/A | 200 | NA | Smoking Cessation | Eran Elinav | Smoking Cessation, Weight Gain | 06/23 | 09/24 | | |
| Recruiting | N/A | 400 | RoW | | Weizmann Institute of Science, Schneider Children's Medical Center, Israel, University of Naples | Personalized Nutrition In Children, Glucose, High Blood, Diet Habit | 12/25 | 12/25 | | |
NCT04633369: The Role of the Microbiome in the Response to Dietary Fibers Intake During Intermediate Fasting |
|
|
| Recruiting | N/A | 100 | RoW | dietary fibers | Weizmann Institute of Science, Hadassah Medical Organization | Dietary Fibers, Intermediate Fasting | 08/25 | 08/25 | | |
NCT05951972: Characterization of Small Molecule Profiles in the Healthy Human Gastrointestinal Tract |
|
|
| Recruiting | N/A | 30 | RoW | nutritional | Eran Elinav | Nutrition, Healthy | 04/26 | 05/26 | | |
NCT04283864: Decoding Personalized Nutritional, Microbiome and Host Patterns Impacting Clinical and Prognostic Features in Crohn's Disease |
|
|
| Recruiting | N/A | 300 | Europe, RoW | | Weizmann Institute of Science, The Leona M. and Harry B. Helmsley Charitable Trust | Crohn Disease | 12/25 | 12/25 | | |
| Completed | N/A | 138 | RoW | Metformin + Healthy diet, Metformin + Healthy (low fat) diet, Metformin + Personalized diet | Garvan Institute of Medical Research, Weizmann Institute of Science | Pre Diabetes, Type 2 Diabetes Mellitus | 12/23 | 07/24 | | |
NCT05972317: The Stool Microbiome of Treated and Untreated IBS (Irritable Bowel Syndrome) Patients |
|
|
| Recruiting | N/A | 200 | RoW | Low FODMAP dietary regimen | Weizmann Institute of Science | Irritable Bowel Syndrome | 11/24 | 11/25 | | |
| Cohen, Yotam |
NCT05972317: The Stool Microbiome of Treated and Untreated IBS (Irritable Bowel Syndrome) Patients |
|
|
| Recruiting | N/A | 200 | RoW | Low FODMAP dietary regimen | Weizmann Institute of Science | Irritable Bowel Syndrome | 11/24 | 11/25 | | |
